Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$12.15 - $35.28 $4.1 Million - $11.9 Million
-337,617 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$30.49 - $48.49 $7.52 Million - $12 Million
-246,664 Reduced 42.22%
337,617 $11.5 Million
Q3 2021

Nov 12, 2021

BUY
$41.66 - $52.52 $742,381 - $935,906
17,820 Added 3.15%
584,281 $28.2 Million
Q2 2021

Aug 13, 2021

BUY
$36.62 - $51.69 $7.46 Million - $10.5 Million
203,619 Added 56.12%
566,461 $25.6 Million
Q1 2021

May 17, 2021

BUY
$41.56 - $59.88 $15.1 Million - $21.7 Million
362,842 New
362,842 $17.5 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.76B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Lombard Odier Asset Management (Switzerland) Sa Portfolio

Follow Lombard Odier Asset Management (Switzerland) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.